Glecaprevir/pibrentasvir (G/P), sold under the brand names Mavyret and Maviret, is a fixed-dose combination medication used to treat hepatitis C. It contains...
10 KB (870 words) - 03:38, 14 April 2024
Pibrentasvir is an NS5A inhibitor antiviral agent. In the United States and Europe, it is approved for use with glecaprevir as the combination drug...
4 KB (136 words) - 19:28, 20 December 2023
in patients' blood. HCV genotype 1a (no cirrhosis): 8 weeks of glecaprevir/pibrentasvir or ledipasvir/sofosbuvir (the latter for people who do not have...
109 KB (11,849 words) - 12:08, 16 August 2024
drug application to the U.S. Food and Drug Administration for the glecaprevir/pibrentasvir (trade name Mavyret) regimen for the treatment of all major genotypes...
6 KB (328 words) - 13:27, 6 June 2024
Gutta-percha, used in endodontic treatment to obturate root canals Glecaprevir/pibrentasvir, medication used to treat hepatitis C .gp, the Internet top-level...
5 KB (713 words) - 22:18, 10 April 2024
Daclatasvir/sofosbuvir (daclatasvir + sofosbuvir) Glecaprevir/pibrentasvir (glecaprevir + pibrentasvir) Ravidasvir Sofosbuvir Sofosbuvir/velpatasvir (sofosbuvir...
67 KB (4,835 words) - 05:59, 17 August 2024
Radalbuvir†Uprifosbuvir†Combination drugs Elbasvir/grazoprevir Glecaprevir/pibrentasvir Ledipasvir/sofosbuvir# Ombitasvir/paritaprevir/ritonavir# Sofosbuvir/daclatasvir...
26 KB (2,541 words) - 05:04, 4 January 2024
Daclatasvir/sofosbuvir (daclatasvir + sofosbuvir) Glecaprevir/pibrentasvir (glecaprevir + pibrentasvir) Sofosbuvir Sofosbuvir/velpatasvir (sofosbuvir +...
38 KB (2,574 words) - 03:03, 15 July 2024
mutation Ibrutinib Pharmacyclics chronic graft-versus-host disease Glecaprevir/pibrentasvir AbbVie hepatitis C Cytarabine/daunorubicin Celator Pharmaceuticals...
34 KB (180 words) - 22:09, 8 April 2024
to attain SVR12 at the end of the 12-week course of treatment. Glecaprevir/Pibrentasvir The Phase 3, multi-center EXPEDITION-2 Study showed that an 8-week...
28 KB (3,543 words) - 11:12, 31 July 2024